Study Stopped
Due to the COVID epidemics, starting with patient recruitement was not possible.
Influence of Respiratory Mechanics on Brain-specific Monitoring in Brain-injured Patients
ABIVENT
Effects of Chest Wall and Lung Elastances on Intracranial Pressure and Brain-specific Multimodal Monitoring in Ventilated Brain Injured Patients
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Increase in intracranial pressure (ICP) could be associated with increase in positive end-expiratory pressure (PEEP) level. Data are however disparate and interactions between ventilation with high PEEP and intracranial circulation are still debated. Individual patient's chest wall elastance could have a key role in determining the effects of PEEP on ICP, since it dictates which proportion of the applied PEEP is transmitted to the pleural space, thus increasing central venous pressure (CVP) and reducing cerebral venous return. Measurement of esophageal pressure with a dedicated probe allows partitioning of respiratory system elastance into its lung and chest wall components, thus permitting to study this phenomenon. Multimodal intracranial monitoring permits to study the effects of PEEP on more advanced brain-specific indices such as brain tissue oxygen (PtiO2), cerebral microdialysis data, transcranial doppler ultrasound-derived flow measurements and automated pupillometry, besides ICP. This study aims to test the association between the ratio of chest wall to respiratory system elastance and PEEP-induced variations in ICP and brain-specific multimodal monitoring indices. This study will evaluate the relative role of other selected measures of respiratory mechanics, hemodynamic variables and intracranial compliance, in order to establish the role of individual respiratory mechanics in the interplay of physiological factors affecting the effects of positive pressure ventilation on the brain. Patients will undergo two periods of ventilation at two different levels of PEEP (5 and 15 cmH2O) in a randomized cross-over order. At the end of each period, cardiorespiratory clinical data, ICP and other advanced multimodal neuromonitoring data (brain tissue oxygen tension, cerebral microdyalisis analytes, transcranial doppler ultrasound and automated infrared pupillometry data) will be collected. Systematic respiratory mechanics assessment (including calculation of chest wall and lung elastances and estimation of the amount of recruitment versus overdistension due to PEEP by means of a single-breath derecruitment trial), echocardiography and arterial blood gas analysis will be performed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2019
CompletedFirst Posted
Study publicly available on registry
July 10, 2019
CompletedStudy Start
First participant enrolled
August 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 2, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 2, 2020
CompletedJune 11, 2021
November 1, 2020
1.3 years
July 1, 2019
June 8, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation between Ers/Ecw and change in ICP between the two PEEP levels
Respiratory mechanics; intracranial pressure monitoring Ers/Ecw = chest wall to respiratory system elastances ratio; ICP = intracranial pressure
Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes
Secondary Outcomes (19)
Correlation between Ecw/Ers and the following neuromonitoring indices at the two PEEP levels: PtiO2, LPR, NPI; MFV, DFV and PI.
Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes
Effect of the two different levels of PEEP on NPI.
Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes
Effect of the two different levels of PEEP on the following transcranial doppler ultrasound variables: MFV, DFV and PI.
Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes
Effect of the two different levels of PEEP on LPR.
Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes
Effect of the two different levels of PEEP on PtiO2.
Recorded every minute during 10 minutes at the end of each 45-minute period (PEEP 5 and 15 cmH2O), 90 minutes
- +14 more secondary outcomes
Study Arms (2)
PEEP level 5 cmH2O to 15 cmH2O
EXPERIMENTALPEEP level 15 cmH2O to 5 cmH2O
EXPERIMENTALInterventions
PEEP level set for 45 minutes
PEEP level set for 45 minutes
Eligibility Criteria
You may qualify if:
- Acute brain injury of any etiology requiring multimodal brain monitoring (intraparenchymal intracranial pressure, brain-tissue oxygen tension and cerebral microdialysis)
- Controlled mechanical ventilation via endotracheal tube
- Patient needing deep sedation
You may not qualify if:
- pregnancy
- contraindications to nasogastric probe placement: basilar skull or significant naso-facial fractures, significant esophageal or gastric trauma or bleeding, previous esophageal surgery, significant bleeding diathesis (spontaneous aPTT \> 60 sec, PT \< 40%, INR \> 1.8, platelets \< 50000/mm3), known esophageal or gastric varices
- decompressive craniectomy
- intracranial pressure monitoring method other than intraparenchymal (e.g. connected to external ventricular drain)
- severe relevant physiological instability contraindicating an increase in PEEP: severe baseline intracranial pressure elevation (\> 20 mmHg), severe hemodynamic instability (defined as norepinephrine requirements \> 0.5 μg/kg/min or cardiogenic shock, defined as any use of dobutamine)
- conditions that interfere with accurate measurements of respiratory mechanics: bronchopleural fistula, pneumothorax.
- Withhold of life-sustaining therapy for medical reasons
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lausanne University Hospitals
Lausanne, Canton of Vaud, 1011, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lise Piquilloud, MER&PD
University of Lausanne Hospitals
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Sponsor-Investigator
Study Record Dates
First Submitted
July 1, 2019
First Posted
July 10, 2019
Study Start
August 1, 2019
Primary Completion
November 2, 2020
Study Completion
November 2, 2020
Last Updated
June 11, 2021
Record last verified: 2020-11